AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Prelude Therapeutics Inc Director's Dealing 2021

Dec 1, 2021

34339_dirs_2021-12-01_3b8e42d4-27be-4241-b3da-94a942090b6a.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Prelude Therapeutics Inc (PRLD)
CIK: 0001678660
Period of Report: 2021-11-29

Reporting Person: Chardonnet Laurent (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3000	Direct